Pro Medicus Ltd
PME
Company Profile
Business description
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.
Contact
450 Swan Street
RichmondVIC3121
AUST: +61 394298800
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
30 June 2025
Employees
75
Pro Medicus Ltd News & Analysis
personal-finance
Howard Marks warns of stock market froth
The renowned investor has penned his first investor letter for 2025 and it’s a ripper. He runs through what bubbles are, which ones he’s experienced, and whether today’s markets qualify as the third major bubble of this century.
stocks
What we think of the 3 big winners of the ASX 100
Exploring the ASX companies who dominated the market this year
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,687.90 | 93.50 | 1.09% |
| CAC 40 | 7,733.50 | 23.75 | 0.31% |
| DAX 40 | 20,990.31 | 86.92 | 0.42% |
| Dow JONES (US) | 43,487.83 | 334.70 | 0.78% |
| FTSE 100 | 8,520.54 | 15.32 | 0.18% |
| HKSE | 19,925.81 | 341.75 | 1.75% |
| NASDAQ | 19,630.20 | 291.91 | 1.51% |
| Nikkei 225 | 39,056.11 | 153.61 | 0.39% |
| NZX 50 Index | 13,125.20 | 36.89 | 0.28% |
| S&P 500 | 5,996.66 | 59.32 | 1.00% |
| S&P/ASX 200 | 8,441.10 | 93.70 | 1.12% |
| SSE Composite Index | 3,244.38 | 2.56 | 0.08% |